Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis.

Bente P van den Boom Fien A von MeijenfeldtJelle AdelmeijerLara N RobertsWilliam BernalJ P Luyendyk

Published in: Journal of thrombosis and haemostasis : JTH (2021)

These data suggest that current prophylactic heparin doses have comparable anticoagulant effects in patients with cirrhosis compared with patients without underlying liver disease.

Keyphrases

venous thromboembolism
end stage renal disease
chronic kidney disease
ejection fraction
peritoneal dialysis
prognostic factors
growth factor